Evidence map›Paper›PMID 28172359›Full record

ArticleBioinformatics (Oxford, England)2017

CIIPro: a new read-across portal to fill data gaps using public large-scale chemical and biological data.

Daniel P Russo, Marlene T Kim, Wenyi Wang, Daniel Pinolini, Sunil Shende, Judy Strickland, Thomas Hartung, Hao Zhu

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Comparing the performance and coverage of selectedComputational toxicology (Amsterdam, Netherlands) · 2022
    Article
  9. High-Throughput Screening Assay Profiling for Large Chemical Databases.Methods in molecular biology (Clifton, N.J.) · 2022
    Article
  10. Article
  11. Review
  12. Mechanism-Driven Read-Across of Chemical Hepatotoxicants Based on Chemical Structures and Biological Data.Toxicological sciences : an official journal of the Society of Toxicology · 2020
    Article
  13. Big Data and Artificial Intelligence Modeling for Drug Discovery.Annual review of pharmacology and toxicology · 2020
    Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Daniel P RussoThe Rutgers Center for Computational and Integrative Biology, Camden, NJ, USA.
Marlene T KimThe Rutgers Center for Computational and Integrative Biology, Camden, NJ, USA.
Wenyi WangThe Rutgers Center for Computational and Integrative Biology, Camden, NJ, USA.
Daniel PinoliniThe Rutgers Center for Computational and Integrative Biology, Camden, NJ, USA.
Sunil ShendeThe Rutgers Center for Computational and Integrative Biology, Camden, NJ, USA.
Judy StricklandILS, Research Triangle Park, NC, USA.
Thomas HartungJohns Hopkins Bloomberg School of Public Health, Center for Alternatives to Animal Testing (CAAT), Baltimore, MD, USA.
Hao ZhuThe Rutgers Center for Computational and Integrative Biology, Camden, NJ, USA.

Funding

Translational Research Support CoreP30ES005022 · NIEHS · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI ROBERT John LAUMBACH · 1988 to 2026
$47.4M
Predictive Computational Acute Toxicity Modeling by Profiling Chemicals With PublR15ES023148 · NIEHS · RUTGERS THE STATE UNIV OF NJ CAMDEN · PI ZHU, HAO · 2013 to 2018
$941k
NIEHS NIH HHS HHSN273201500010CNIEHS NIH HHS P30 ES005022NIEHS NIH HHS R15 ES023148
6 · The paper itself

Abstract

Summary: We have developed a public Chemical In vitro–In vivo Profiling (CIIPro) portal, which can automatically extract in vitro biological data from public resources (i.e. PubChem) for user-supplied compounds. For compounds with in vivo target activity data (e.g. animal toxicity testing results), the integrated cheminformatics algorithm will optimize the extracted biological data using in vitro–in vivo correlations. The resulting in vitro biological data for target compounds can be used for read-across risk assessment of target compounds. Additionally, the CIIPro portal can identify the most similar compounds based on their optimized bioprofiles. The CIIPro portal provides new powerful assessment capabilities to the scientific community and can be easily integrated with other cheminformatics tools. Availability and Implementation: ciipro.rutgers.edu. Contact: danrusso@scarletmail.rutgers.edu or hao.zhu99@rutgers.edu

Indexed as

SoftwareAnimalsBiosimilar PharmaceuticalsComputational BiologyRisk AssessmentToxicologyBiosimilar Pharmaceuticals

Identifiers

PMID28172359
PMCPMC6075082

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.